僅用于工業(yè)應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Semorinemab （RG 6100） is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein （amino acid residues 6-23）. Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease